These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9384469)

  • 21. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
    Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs.
    Lancaster DL; Adio RA; Tai KK; Simooya OO; Broadhead GD; Tucker GT; Lennard MS
    J Pharm Pharmacol; 1990 Apr; 42(4):267-71. PubMed ID: 1974295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
    Haaz MC; Riché C; Rivory LP; Robert J
    Drug Metab Dispos; 1998 Aug; 26(8):769-74. PubMed ID: 9698291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system.
    Haehner T; Refaie MO; Müller-Enoch D
    Arzneimittelforschung; 2004; 54(1):78-83. PubMed ID: 14979613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.
    Wrighton SA; Ring BJ
    Pharm Res; 1994 Jun; 11(6):921-4. PubMed ID: 7937537
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.
    Shu Y; Wang LS; Xu ZH; He N; Xiao WM; Wang W; Huang SL; Zhou HH
    J Pharmacol Exp Ther; 2000 Nov; 295(2):844-51. PubMed ID: 11046127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam.
    Hesse LM; Venkatakrishnan K; von Moltke LL; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2001 Feb; 29(2):133-40. PubMed ID: 11159802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
    Tuvesson H; Hallin I; Persson R; Sparre B; Gunnarsson PO; Seidegård J
    Drug Metab Dispos; 2005 Jun; 33(6):866-72. PubMed ID: 15764719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms.
    Abbas R; Chow CP; Browder NJ; Thacker D; Bramer SL; Fu CJ; Forbes W; Odomi M; Flockhart DA
    Hum Exp Toxicol; 2000 Mar; 19(3):178-84. PubMed ID: 10889516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.
    Royer I; Monsarrat B; Sonnier M; Wright M; Cresteil T
    Cancer Res; 1996 Jan; 56(1):58-65. PubMed ID: 8548776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes.
    Yeo KR; Yeo WW
    Br J Clin Pharmacol; 2001 May; 51(5):461-70. PubMed ID: 11422004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
    Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
    J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and elimination of quinine in healthy volunteers.
    Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
    Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.